跳至主要内容
临床试验/NCT06784895
NCT06784895招募中不适用

Designing and Assessing a Women Only Cardiac Rehabilitation Program

University of Michigan1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年5月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Cardiac Rehabilitation (CR) attendance rate - percentage

研究概览

简要总结

The purpose of this randomized controlled study is to investigate the effect(s) of a pilot women-only cardiac rehabilitation (CR) program. The study team will be testing the effectiveness, compliance and enjoyment of this women's only cardiac rehabilitation (CR) program by comparing outcomes to those randomized to receive Michigan Medicine's current CR program (standard care), which includes people of all genders.

Study hypotheses:

  • Women randomized to women-specific CR programming will have superior attendance and completion rates compared to women attending mixed-sex CR programming.
  • Women randomized to women-specific CR programming will experience greater improvement in clinical outcomes in comparison to those in mixed-sex CR programming.

详细描述

This registration was updated on 11/24/2025 due to amendments that were approved at the IRBMED.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The study team will make every effort to:

  • Mask the Cardiopulmonary Exercise Test (CPET)/Volume of Oxygen consumed (VO2) test technicians that will be administering these assessments from knowing which treatment arm the participant is receiving.
  • Mask the registered dietician as to which study participants are in the control group and are receiving the standard CR programming (unable to blind for experimental group due to the nature of the group CR sessions)
  • Mask the statistician as to which group received which CR programming during data analysis.
  • Limit contact and conversation between participants and non-CR staff; example lab technicians, nurses, medical assistants, and dietitians

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Provision of signed and dated informed consent form
  • •Stated willingness to comply with all study procedures and availability to participate in study procedures for the duration of the study
  • •Identify as a female
  • •Be between the ages of 40-80 years, inclusive
  • •Documented diagnosis of CR indications of stable angina pectoris, acute myocardial infarction (MI) within the preceding 6 months, percutaneous coronary interventions (PCI), surgical and transvalvular aortic valve replacement, post-aortic surgery with or without aortic valve, coronary artery bypass grafting (CABG) and mitral valve replacement or repair with or without CABG
  • •Referred to outpatient CR at the University of Michigan, Domino's Farms or Brighton Center for Specialty Care Cardiac Rehabilitation site based on Michigan Medicine's Division of Cardiovascular Medicine Policy and Procedure.

排除标准

  • •Not being "cleared" for CR based on Michigan Medicine's Division of Cardiovascular Medicine Policy and Procedures
  • •Prior participation in CR
  • •Inability to understand spoken and written English, either due to language barrier or cognitive limitation for any reason, including deaf or blind
  • •Frailty, fall risk, or muscle, joint or back pain as defined as the inability to perform activities of daily living without limitations and engage in mild physical activity (i.e. unable to walk up 1 flight of stairs unaided)
  • •Any of the following as the indication for CR: aortic repair or replacement for aortic dissection, untreated or greater than New York Heart Association (NYHA) class II congestive heart failure, coronary artery dissection without coronary artery disease, fibromuscular hyperplasia, stress cardiomyopathy, cardiac transplant candidate or recipient
  • •Life threatening ventricular arrythmias without an implanted defibrillator; very frequent premature ventricular contraction or premature atrial contractions symptomatic or not; poorly controlled atrial fibrillation
  • •Associated more than mild valvular heart disease, untreated congestive heart failure; unstable angina or heart pain with minimal activity; angina or congestive heart failure limiting ability to climb one flight of stairs without help (NHYA Functional Classification >2)
  • •Severe pulmonary hypertension (right heart systolic pressure greater than 60 millimeters of mercury); clot in the heart; treated venous thrombosis with or without pulmonary embolism in past 6 months; more than mild dyspnea related to chronic lung disease or asthma
  • •Chronic kidney disease (creatinine >2 milligrams per deciliter (mg/dl)); symptomatic active liver disease (infectious or inflammatory), symptomatic chronic liver disease (except for nonalcoholic fatty liver disease), kidney dialysis or kidney transplant recipient, active or chronic renal disease (rise by 0.5mg/dL in past 3 months or chronic elevated serum creatinine 2.0 milligrams per milliliter (mg/mL) or greater.
  • •Poorly controlled diabetes defined as uninterrupted HbA1c >8.0% for ≥1 year despite standard care, baseline HbA1c prior to CR > 8.5%.
  • •Immunosuppressive drug requirement, acute anemia, chronic anemia with Hemoglobin < 10mg/mL
  • •Limiting chronic muscle, joint, or back pain; identified as fall risk from poor balance or neurologic syndromes; frailty defined as the inability to perform activities of daily living in older adults that carries an increased risk for poor health outcomes including falls, incident disability, hospitalization, and mortality
  • •Untreated or active substance abuse/addiction including alcohol and drugs; depression (defined as a score ≥ 15 or depression positive answer to #8 or #9 on Patient Health Questionnaire-9) unless deemed acceptable by mental health care provider; severe anxiety
  • •Severe obesity (Body mass index ≥ 40 kilograms/meters squared), on weight loss drugs (unless target body weight has been achieved or use is for glycemic control in diabetes), history of bariatric surgery; chronic venous insufficiency with cellulitis or > 1+ edema unless controlled with support hose.

研究组 & 干预措施

Women only Cardiac Rehab program

Experimental

干预措施: Women only Cardiac Rehab program (Behavioral)

Standard of Care (mixed-sex) rehab program

Active Comparator

干预措施: Standard of Care (mixed-sex) rehab program (Behavioral)

结局指标

主要结局

Cardiac Rehabilitation (CR) attendance rate - percentage

时间窗: 12 weeks (post CR)

Number of CR sessions attended out of number of CR sessions prescribed, expressed as a percentage

Cardiac Rehabilitation (CR) attendance rate

时间窗: 12 weeks (post CR)

CR completion rate defined as number of patients that "graduated" or completed CR programming versus the number of patients that started CR programming \[i.e. attended 75% or more of the prescribed sessions (≥27 out of 36)\], expressed as a percentage of participants per arm.

次要结局

  • Change in resting diastolic blood pressure (DBP)(Baseline, 12 weeks (post CR))
  • Change in 6-minute walk test distance(Baseline, 12 weeks (post CR))
  • Improvement in functional capacity measured by the six-minute walk test(Baseline, up to 12 weeks (post CR))
  • Optimal blood pressure (BP) control(12 weeks (post CR))
  • Change in resting systolic blood pressure (SBP)(Baseline, 12 weeks (post CR))
  • Improvement in depression based on the Patient Health Questionnaire (PHQ)-9(Baseline to 12 weeks (post CR))
  • Change in Patient Health Questionnaire (PHQ)-9 score(12 weeks (post CR), 24 weeks)
  • Improvement in functional capacity Metabolic Equivalents (METs)(Baseline, 12 weeks (post CR))
  • Change in estimated exercise session peak METs(Baseline, up to 12 weeks (post CR))
  • Change in Patient Health Questionnaire (PHQ)-9 score(Baseline to 12 weeks (post CR))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Melvyn Rubenfire

Professor of Internal Medicine

University of Michigan

研究点 (1)

Loading locations...

相似试验

Designing and Assessing a Women Only Cardiac... | 临床试验